Mupina (Mupirocin)

Mupirocin, the active ingredient in Mupina, is an antibiotic (monoxycarbolic acid) presented as a topical ointment for nasal use. It is employed to eradicate Staphylococcus aureus, including methicillin‑resistant strains, from the nasal passages of carriers and patients at risk of infection, supporting infection control measures in clinical settings.

GNH USA supplies Mupina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with European Union quality standards and is manufactured under GMP conditions.

Mupina (mupirocin) is used for nasal decolonisation of Staphylococcus aureus, targeting carriers to reduce infection risk. - Nasal decolonisation of Staphylococcus aureus (including MRSA): reduces bacterial carriage in the anterior nares. - Pre‑operative nasal decolonisation: lowers the likelihood of postoperative Staphylococcal wound infections. - Carrier eradication in healthcare workers: helps eliminate nasal colonisation to prevent transmission in clinical environments.

Mupina may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Pruritus: itching of the nasal mucosa. - Rhinorrhea: watery nasal discharge. - Headache: mild tension‑type headache.

Serious or Rare Side Effects: - Allergic contact dermatitis: redness, swelling, or vesicles at the application site. - Anaphylaxis: rare systemic hypersensitivity with respiratory distress or hypotension. - Superinfection: overgrowth of non‑susceptible organisms leading to secondary infection.

When using Mupina, consider the following precautions to ensure safe and effective treatment. - Indication verification: confirm nasal colonisation with Staphylococcus aureus before treatment. - Duration of therapy: limit use to the prescribed period to avoid resistance development. - Concomitant antibiotics: avoid simultaneous use of other topical antibiotics in the same area. - Pregnancy and lactation: assess risk‑benefit ratio as safety data are limited. - Pediatric use: use only under medical supervision in children. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mupina can interact with other medicines; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Systemic antibiotics with similar spectrum: may increase risk of resistance. - Immunosuppressants: heightened risk of infection when bacterial load is not controlled.

Moderate Interactions (Monitor Closely): - Antifungal agents applied to the same site: potential for local irritation. - Nasal decongestants: may alter mucosal absorption of mupirocin. - Topical corticosteroids: could mask signs of local infection.